Sign In
Buy LABU
$165.45
+7.29 (+4.61%)
At Close: Jun 03, 2026
BIB Versus LABU: Comparing Leveraged Biotech ETFs
02:50pm, Tuesday, 25'th Jun 2019
Read a comparison of BIB and LABU and a description of the characteristics and historical performance of these leveraged biotech ETFs.
It's Time To Consider Leveraged Healthcare ETFs
01:29pm, Friday, 07'th Jun 2019
With one of the industry's marquee conferences recently ending, traders may want to consider the Direxion Daily Healthcare Bull 3X Shares (NYSE: CURE) and the Direxion Daily S&P; Biotech Bull 3X Shar
5 Leveraged ETFs With Biggest 1-Month Fund Flows
11:00am, Wednesday, 22'nd May 2019
For the past month, leveraged exchange-traded fund (ETF) traders have been feasting off opportunities in gold, biotech, large caps, and semiconductors as the U.S.-China trade deal went awry. The fligh
7 ETFs for Investors With a Gambler’s Spirit
03:35pm, Tuesday, 07'th May 2019
Exchange-traded funds (ETFs) are often aimed at conservative investors with long-term time horizons. Many of the largest ETFs on the market today are designed to provide cost-effective exposure to bas
Weekly ETF Gainers / Losers (04/26/19)
08:30pm, Friday, 26'th Apr 2019
No summary available.
Big Moves In Leveraged Biotech ETFs
01:25pm, Tuesday, 09'th Apr 2019
Leveraged biotechnology exchange traded funds (ETFs) are known to make big moves, but sometimes those moves are not always about price action. What Happened Entering Monday, the Direxion Daily S&P; Bi
Week 11 Breakout Forecast: Short-Term Picks To Give You An Edge
02:03pm, Monday, 11'th Mar 2019
No summary available.
March: Exploiting Sector ETF Seasonality Patterns For Best Stock Gains
05:21pm, Thursday, 07'th Mar 2019
No summary available.
